Effepharm , the first NMN raw material manufacturer to do clinical trials

by Sep 23, 2019Company news

Effepharm , the first NMN raw material manufacturer to do clinical trials

Clinical trials drive innovation and progress

Which means
High-end brand raw material supplier
Strong brand competitiveness
Great market share

We are always on the road

In September We were invited to the China-Australia Clinical Research Executive Summit as the only food ingredient company. All the other attendees were from pharmaceutical companies.

NMN Clinical Trial conference
With an all-star R&D team, whose members came from top pharmaceutical companies like GSK in the US and international organizations like USP, we know the difference between dietary food and normal food. And we’re proud to be the first ingredient manufacturer to conduct the clinical trial on our Uthever NMN ingredient.

Our clinical study would include:
(1) Safety assessment
(2) Anti-aging
(3) Boosting energy

Prior to this clinical study, we would also conduct preclinical study, which would include:
(1) Acute toxicity study
(2) 90-day subchronic oral study
(3) Bacterial mutagenesis-Ames
(4) In vitro cytogenetics-Chromosome aberration test in CHO cell lines
(5) In vivo mammalian test-Chromosome aberration test in Mouse

Effepharm is committed to conducting rigorous research and will share them with our customers and the public.

 

Related News